We present new developments for an ab-initio model of the neutron relative biological effectiveness (RBE) in inducing specific classes of DNA damage. RBE is evaluated as a function of the incident neutron energy and of the depth inside a human-sized reference spherical phantom. The adopted mechanistic approach traces neutron RBE back to its origin, i.e. neutron physical interactions with biological tissues. To this aim, we combined the simulation of radiation transport through biological matter, performed with the Monte Carlo code PHITS, and the prediction of DNA damage using analytical formulas, which ground on a large database of biophysical radiation track structure simulations performed with the code PARTRAC. In particular, two classes of DNA damage were considered: sites and clusters of double-strand breaks (DSBs), which are known to be correlated with cell fate following radiation exposure. Within a coherent modelling framework, this approach tackles the variation of neutron RBE in a wide energy range, from thermal neutrons to neutrons of hundreds of GeV, and reproduces effects related to depth in the human-sized receptor, as well as to the receptor size itself. Besides providing a better mechanistic understanding of neutron biological effectiveness, the new model can support better-informed decisions for radiation protection: indeed, current neutron weighting (ICRP)/quality (U.S. NRC) factors might be insufficient for use in some radiation protection applications, because they do not account for depth. RBE predictions obtained with the reported model were successfully compared to the currently adopted radiation protection standards when the depth information is not relevant (at the shallowest depth in the phantom or for very high energy neutrons). However, our results demonstrate that great care is needed when applying weighting factors as a function of incident neutron energy only, not explicitly considering RBE variation in the target. Finally, to facilitate the use of our results, we propose look-up RBE tables, explicitly considering the depth variable, and an analytical representation of the maximal RBE vs. neutron energy.
In proton therapy, most treatment planning systems (TPS) use a fixed relative biological effectiveness (RBE) of 1.1 all along the depth-dose profile. Innovative TPS are now investigated considering the variability of RBE with radiation quality. New TPS need an experimental verification in the quality assurance (QA) routine in clinics, but RBE data are usually obtained with radiobiological measurements that are time consuming and not suitable for daily QA. Microdosimetry is a useful tool based on physical measurements which can monitor the radiation quality. Several microdosimeters are available in different research institutions, which could potentially be used for the QA in TPS. In this study, the response functions of five detectors in the same 62-MeV proton Spread Out Bragg Peak is compared in terms of spectral distributions and their average values and microdosimetric RBE. Their different response function has been commented and must be considered in the clinical practice.
- MeSH
- protonová terapie * MeSH
- protony * MeSH
- radiometrie MeSH
- relativní biologická účinnost MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- protony * MeSH
The topic of the article is to define the average value of linear energy transfer (LET) for carcinogenic effects of radon progeny. The microdosimetric model of boundary specific energy is used. It follows that the effect at high LET should decrease approximately with the third power of LET. This is verified by the analysis of the relationship between radiation effects ratio and LET in published experiments with oncogenic transformation of mammalian cells irradiated with the monoenergetic alpha particles. If these cells are exposed with the radon irradiator, our analysis leads us to conclude that the oncogenic effect of radon progeny is comparable to that of alpha particles with a LET of 75 keV/μm. It is about a quarter lower than the LET value, where the effect of the monoenergetic alpha particles reaches its maximum level. Some implications for lung cancer due to radon inhalation may also be carefully examined.
- MeSH
- alfa částice * MeSH
- dceřiné produkty radonu škodlivé účinky MeSH
- karcinogeneze * MeSH
- křeček rodu Mesocricetus MeSH
- lidé MeSH
- lineární přenos energie * MeSH
- myši inbrední C3H MeSH
- myši MeSH
- nádorová transformace buněk účinky záření MeSH
- nádory plic MeSH
- nádory vyvolané zářením MeSH
- onkogeny MeSH
- radon škodlivé účinky MeSH
- relativní biologická účinnost * MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- dceřiné produkty radonu MeSH
- radon MeSH
The biophysical simulation tool PARTRAC has been primarily developed to model radiation physics, chemistry and biology on nanometre to micrometre scales. However, the tool can be applied in simulating radiation effects in an event-by-event manner over macroscopic volumes as well. Benchmark simulations are reported showing that PARTRAC does reproduce the macroscopic Bragg peaks of proton beams, although the penetration depths are underestimated by a few per cent for high-energy beams. PARTRAC also quantifies the increase in DNA damage and its complexity along the beam penetration depth. Enhanced biological effectiveness is predicted in particular within distal Bragg peak parts of therapeutic proton beams.
- MeSH
- algoritmy MeSH
- DNA účinky záření MeSH
- dvouřetězcové zlomy DNA účinky záření MeSH
- lineární přenos energie MeSH
- metoda Monte Carlo MeSH
- počítačová simulace * MeSH
- poškození DNA MeSH
- protonová terapie MeSH
- protony MeSH
- relativní biologická účinnost MeSH
- software MeSH
- voda MeSH
- výpočetní biologie MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- DNA MeSH
- protony MeSH
- voda MeSH
Protontherapy is hadrontherapy's fastest-growing modality and a pillar in the battle against cancer. Hadrontherapy's superiority lies in its inverted depth-dose profile, hence tumour-confined irradiation. Protons, however, lack distinct radiobiological advantages over photons or electrons. Higher LET (Linear Energy Transfer) 12C-ions can overcome cancer radioresistance: DNA lesion complexity increases with LET, resulting in efficient cell killing, i.e. higher Relative Biological Effectiveness (RBE). However, economic and radiobiological issues hamper 12C-ion clinical amenability. Thus, enhancing proton RBE is desirable. To this end, we exploited the p + 11B → 3α reaction to generate high-LET alpha particles with a clinical proton beam. To maximize the reaction rate, we used sodium borocaptate (BSH) with natural boron content. Boron-Neutron Capture Therapy (BNCT) uses 10B-enriched BSH for neutron irradiation-triggered alpha particles. We recorded significantly increased cellular lethality and chromosome aberration complexity. A strategy combining protontherapy's ballistic precision with the higher RBE promised by BNCT and 12C-ion therapy is thus demonstrated.
- MeSH
- alfa částice terapeutické užití MeSH
- bor chemie terapeutické užití MeSH
- borohydridy chemie MeSH
- buněčná smrt účinky záření MeSH
- chromozomální aberace účinky záření MeSH
- cyklotrony MeSH
- DNA nádorová genetika metabolismus účinky záření MeSH
- fluorescenční barviva chemie MeSH
- izotopy uhlíku chemie MeSH
- karyotypizace MeSH
- kombinovaná terapie přístrojové vybavení metody MeSH
- lidé MeSH
- lineární přenos energie MeSH
- nádorové buněčné linie MeSH
- nádory prostaty patologie radioterapie MeSH
- neutrony * MeSH
- poškození DNA MeSH
- protonová terapie * přístrojové vybavení metody MeSH
- relativní biologická účinnost MeSH
- sulfhydrylové sloučeniny chemie MeSH
- terapie metodou neutronového záchytu (bor-10) přístrojové vybavení metody MeSH
- vztah dávky záření a odpovědi MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- bor MeSH
- borohydridy MeSH
- DNA nádorová MeSH
- fluorescenční barviva MeSH
- izotopy uhlíku MeSH
- mercaptoundecahydrododecaborate MeSH Prohlížeč
- sulfhydrylové sloučeniny MeSH
In recent years, there is an increased interest in using scanning modes in proton therapy, due to the more conformal dose distributions, thanks to the spot-weighted dose delivery. The dose rate in each spot is however much higher than the dose rate when using passive irradiation modes, which could affect the cell response. The purpose of this work was to investigate how the relative biological effectiveness changes along the spread-out Bragg peak created by protons delivered by the pencil beam scanning mode. Cell survival and micronuclei formation were investigated in four positions along the spread-out Bragg peak for various doses. Monte Carlo simulations were used to estimate the dose-averaged linear energy transfer values in the irradiation positions. The cell survival was found to decrease the deeper the sample was placed in the spread-out Bragg peak, which corresponds to the higher linear energy transfer values found using Monte Carlo simulations. The micronuclei frequencies indicate more complex cell injuries at that distal position compared to the proximal part of the spread-out Bragg peak. The relative biological effectiveness determined in this study varies significantly and systematically from 1.1, which is recommended value by the International Commission on Radiation Units, in all the studied positions. In the distal position of spread-out Bragg peak the relative biological effectiveness values were found to be 2.05 ± 0.44, 1.85 ± 0.42, 1.53 ± 0.38 for survival levels 90, 50 and 10%, respectively.
- Klíčová slova
- Clonogennic assay, Micronuclei assay, Monte Carlo simulations, Proton therapy, Relative biological effectiveness, Scanning beam,
- MeSH
- lidé MeSH
- lineární přenos energie MeSH
- mikrojaderné testy MeSH
- novorozenec MeSH
- počítačová simulace MeSH
- protony * MeSH
- radiometrie MeSH
- relativní biologická účinnost * MeSH
- viabilita buněk účinky záření MeSH
- vztah dávky záření a odpovědi MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- protony * MeSH
PURPOSE: To investigate the clinical implications of a variable relative biological effectiveness (RBE) on proton dose fractionation. Using acute exposures, the current clinical adoption of a generic, constant cell killing RBE has been shown to underestimate the effect of the sharp increase in linear energy transfer (LET) in the distal regions of the spread-out Bragg peak (SOBP). However, experimental data for the impact of dose fractionation in such scenarios are still limited. METHODS AND MATERIALS: Human fibroblasts (AG01522) at 4 key depth positions on a clinical SOBP of maximum energy 219.65 MeV were subjected to various fractionation regimens with an interfraction period of 24 hours at Proton Therapy Center in Prague, Czech Republic. Cell killing RBE variations were measured using standard clonogenic assays and were further validated using Monte Carlo simulations and parameterized using a linear quadratic formalism. RESULTS: Significant variations in the cell killing RBE for fractionated exposures along the proton dose profile were observed. RBE increased sharply toward the distal position, corresponding to a reduction in cell sparing effectiveness of fractionated proton exposures at higher LET. The effect was more pronounced at smaller doses per fraction. Experimental survival fractions were adequately predicted using a linear quadratic formalism assuming full repair between fractions. Data were also used to validate a parameterized variable RBE model based on linear α parameter response with LET that showed considerable deviations from clinically predicted isoeffective fractionation regimens. CONCLUSIONS: The RBE-weighted absorbed dose calculated using the clinically adopted generic RBE of 1.1 significantly underestimates the biological effective dose from variable RBE, particularly in fractionation regimens with low doses per fraction. Coupled with an increase in effective range in fractionated exposures, our study provides an RBE dataset that can be used by the modeling community for the optimization of fractionated proton therapy.
- MeSH
- analýza kolonii tvořících jednotek MeSH
- fibroblasty účinky záření MeSH
- frakcionace dávky záření MeSH
- lidé MeSH
- lineární přenos energie * MeSH
- metoda Monte Carlo MeSH
- nejistota MeSH
- protonová terapie metody MeSH
- protony * MeSH
- relativní biologická účinnost * MeSH
- viabilita buněk MeSH
- vztah dávky záření a odpovědi MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- protony * MeSH
An internal contamination with (241)Am was detected in a worker during a routine monitoring of workers from a company producing Am sources for smoke detectors and Am-Be neutron sources. During the 4-year period after the exposure, the number of urine and faecal samples from the worker were analysed; in vivo measurements were also performed. Specific values for absorption parameters of the human respiratory tract model and particle transport values were applied to improve the model fit to the measurement data. A good agreement of the bioassay data with the so-modified model predictions was obtained.
- MeSH
- americium farmakokinetika moč MeSH
- biotest MeSH
- celotělové počítání MeSH
- dospělí MeSH
- hodnocení rizik MeSH
- kosti a kostní tkáň účinky záření MeSH
- lidé MeSH
- obsah radioaktivních látek v organizmu MeSH
- plíce účinky záření MeSH
- počítačová simulace MeSH
- pracovní expozice analýza MeSH
- relativní biologická účinnost MeSH
- tkáňová distribuce MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- americium MeSH
PURPOSE: The purpose of our study is to examine phospho-ATF-2(Thr-69/71) (phospho-activating transcription factor-2, p-ATF-2), phospho-CREB(Ser-133) (phospho-cAMP response binding element protein, p-CREB), and phospho-c-Myc(Thr-58/Ser-62) (phosho-myelocytomatosis protooncogene, p-c-Myc) expression in irradiated rat colon transversum. MATERIALS AND METHODS: Male Wistar rats were randomly divided to 28 groups and irradiated with whole-body gamma-radiation of 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 Gy. Samples were taken 4 and 24 hours after the irradiation, immunohistochemically stained. P-ATF-2, p-CREB, and p-c-Myc expression was measured. RESULTS: We measured increased cytoplasmatic p-ATF-2 expression 4 hours after irradiation by 0.25 - 1, 10 Gy and 24 hours after irradiation by 0.5 - 1, 10 Gy. Increased cytoplasmatic p-CREB expression was found 4 hours after irradiation by 0.25 - 1, 9, 10 Gy and 24 hours after irradiation by 0.25 - 1, 4, 10 Gy. Increased p-c-Myc cytoplasmatic expression was found 4 hours after irradiation by 0.25, 0.75, 4, 5 Gy and 24 hours after irradiation by 0.75, 1, 10 Gy. Nuclear p-ATF-2, p-CREB, and p-c-Myc expressions were similar to their cytoplasmatic expressions. CONCLUSION: The detection of p-ATF-2 and p-CREB might be considered as a perspective biodosimetric tool for irradiated enterocytes in vivo. The use of p-c-Myc appears to be controversial due to the ambivalent expression values.
- MeSH
- biotest metody MeSH
- celotělové ozáření * MeSH
- celotělové počítání metody MeSH
- exprese genu účinky záření MeSH
- kolon metabolismus účinky záření MeSH
- krysa rodu Rattus MeSH
- obsah radioaktivních látek v organizmu MeSH
- potkani Wistar MeSH
- protein vázající element responzivní pro cyklický AMP metabolismus MeSH
- relativní biologická účinnost MeSH
- transkripční faktor ATF2 metabolismus MeSH
- záření gama MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- protein vázající element responzivní pro cyklický AMP MeSH
- transkripční faktor ATF2 MeSH
Radon is recognized as a public health concern for indoor exposure. Precise quantification derived from occupational exposure in miners is still needed for estimating the risk and the factors that modify the dependence on cumulated exposure. The present paper reports on relationship between radon exposure and lung cancer risk in French and Czech cohorts of uranium miners (n = 10,100). Miners from these two cohorts are characterized by low levels of exposure (average cumulated exposure of less than 60 WLM) protracted over a long period (mean duration of exposure of 10 years) and by a good quality of individual exposure estimates (95% of annual exposures based on radon measurements). The modifying effect of the quality of exposure on the risk is analyzed. A total of 574 lung cancer deaths were observed, which is 187% higher than expected from the national statistics. This significantly elevated risk is strongly associated with cumulated radon exposure. The estimated overall excess relative risk per WLM is 0.027 (95% CI: 0.017-0.043, related to measured exposures). For age at exposure of 30 and 20 years since exposure, the ERR/WLM is 0.042, and this value decreases by approximately 50% for each 10-year increase in age at exposure and time since exposure. The present study emphasizes that the quality of exposure estimates is an important factor that may substantially influence results. Time since exposure and simultaneously age at exposure were the most important effect modifiers. No inverse exposure-rate effect below 4 WL was observed. The results are consistent with estimates of the BEIR VI report using the concentration model at an exposure rate below 0.5 WL.
- MeSH
- analýza přežití MeSH
- časové faktory MeSH
- dávka záření MeSH
- dospělí MeSH
- hodnocení rizik metody MeSH
- hornictví statistika a číselné údaje MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- nádory plic mortalita MeSH
- nádory vyvolané zářením mortalita MeSH
- obsah radioaktivních látek v organizmu MeSH
- pracovní expozice statistika a číselné údaje MeSH
- radon analýza MeSH
- relativní biologická účinnost MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- uran analýza MeSH
- věk při počátku nemoci MeSH
- věkové rozložení MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Francie epidemiologie MeSH
- Názvy látek
- radon MeSH
- uran MeSH